-
741
Immunoregulatory programs in anti‐N‐methyl‐D‐aspartate receptor encephalitis identified by single‐cell multi‐omics analysis
Published 2025-01-01“…In parallel, single‐cell B cell receptor sequencing (scBCR‐seq) and repertoire analysis were conducted to assess antigen‐driven clonal expansion within the B cell population. …”
Get full text
Article -
742
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells
Published 2025-02-01“…Abstract: Chimeric antigen receptor (CAR) T cells directed against B-cell maturation antigen (BCMA) are an effective treatment for multiple myeloma (MM), but short persistence and frequent relapses are challenges for this immunotherapy. …”
Get full text
Article -
743
Carbon Material Hybrid Construction on an Aptasensor for Monitoring Surgical Tumors
Published 2022-01-01“…Carcinoembryonic antigen (CEA) is a glycoprotein, one of the common tumor biomarkers, found at low levels in body fluids. …”
Get full text
Article -
744
Establishment of a Rapid and Convenient Fluoroimmunoassay Platform Using Antibodies Against PDL1 and HER2
Published 2025-01-01“…This robust platform can be readily adapted for various fluoroimmunoassays targeting other antigens of interest.…”
Get full text
Article -
745
Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy
Published 2025-02-01“…Naive B cells present the initial antigen, germinal center B cell subsets enhance antibody affinity, and immunoglobulin subtypes exert multiple immune effects, while regulatory B cells establish immune tolerance. …”
Get full text
Article -
746
Transverse Myelitis Associated with Cryptococcus neoformans in an Immunocompetent Patient
Published 2022-01-01“…Analysis of cerebral spinal fluid (CSF) obtained via lumbar puncture was positive for the Streptococcus antigen with cultures also growing Cryptococcus neoformans. …”
Get full text
Article -
747
T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
Published 2010-01-01“…Another important tumor-escape mechanism is to avoid recognition by dysregulation of antigen processing and presentation. Thus, both induction of functional CTL and susceptibility of the tumor and its microenvironment to become T cell targets should be considered in CTL-based immunotherapy.…”
Get full text
Article -
748
Application of Bionanomaterials in Tumor Immune Microenvironment Therapy
Published 2021-01-01“…Immune checkpoint blockade therapy and chimeric antigen receptor T-cell (CAR-T) immunotherapy are clinically effective in a variety of cancers. …”
Get full text
Article -
749
Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes
Published 2012-01-01“…It is important to have an understanding of human-leukocyte antigen (HLA) typing including well-designed studies to determine anti-MHC-class-I-related chain A (MICA) and antibody rejection pathogenesis. …”
Get full text
Article -
750
The Effects of TLR Activation on T-Cell Development and Differentiation
Published 2012-01-01“…Invading pathogens have unique molecular signatures that are recognized by Toll-like receptors (TLRs) resulting in either activation of antigen-presenting cells (APCs) and/or costimulation of T cells inducing both innate and adaptive immunity. …”
Get full text
Article -
751
The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
Published 2021-01-01“…Also, new macrophage-based cell therapeutic technologies recently developed using chimeric antigen receptor bioengineering are exposed, which may overcome all solid tumor physical barriers impeding the current adoptive cell therapies and contribute to developing novel cancer immunotherapies.…”
Get full text
Article -
752
Desensitization: Overcoming the Immunologic Barriers to Transplantation
Published 2017-01-01“…HLA (Human Leucocyte Antigen) sensitization is a significant barrier to successful kidney transplantation. …”
Get full text
Article -
753
Biometallic ions and derivatives: a new direction for cancer immunotherapy
Published 2025-01-01“…Biometallic ions (e.g. zinc, copper, magnesium, manganese, etc.) can assist in enhancing the efficacy of immunotherapy through the activation of immune cells, enhancement of tumor antigen presentation, and improvement of the tumor microenvironment. …”
Get full text
Article -
754
Therapeutic implications for the PD-1 axis in cerebrovascular injury
Published 2025-01-01“…Classically, PD-L1 on antigen-presenting cells or tissues binds PD-1 on T cell surfaces resulting in T cell inhibition. …”
Get full text
Article -
755
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
Published 2017-01-01“…Although the etiology of PBC has not yet been elucidated, human leukocyte antigen (HLA) class II alleles have been consistently associated with disease onset for decades. …”
Get full text
Article -
756
A Patient with Double-Negative VGKC, Peripheral Nerve Hyperexcitability, and Central Nervous System Symptoms: A Postinfectious Autoimmune Disease
Published 2020-01-01“…It is still unknown whether or not there are unidentified extracellular molecular targets within the VGKC-complex, i.e., a novel surface antigen and a pathogenic antibody that can cause affected individuals to develop a peripheral nerve hyperexcitability syndrome. …”
Get full text
Article -
757
Local and Systemic Antibody Responses in Humans with Helicobacter pylori Infection
Published 1999-01-01“…The most dominant antigen was approximately 66 kDa in molecular mass. …”
Get full text
Article -
758
Superior Sagittal Sinus Thrombosis Complicating Typhoid Fever in a Teenager
Published 2012-01-01“…Urine test for Salmonella typhi Vi antigen was positive, and Widal reaction was significant. …”
Get full text
Article -
759
Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies
Published 2025-01-01“…Abstract The development of bispecific antibodies (BsAbs) represents a significant advancement in therapeutic antibody design, enabling the simultaneous targeting of two different antigens. This dual-targeting capability enhances therapeutic efficacy, particularly in complex diseases like cancer, where tumor heterogeneity presents a significant challenge for traditional treatments. …”
Get full text
Article -
760
Myeloid-Related Protein Activity in Rheumatoid Arthritis
Published 2011-01-01“…Engagement of TLRs by the MRP-8/-14 complex may be particularly important for activating antigen-presenting dendritic cells which regulate critical autoimmune responses that promote chronic synovitis characteristic of RA.…”
Get full text
Article